Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    celgene abi-007 | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Abraxane in Treatment of Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: nab-paclitaxel
2 Recruiting Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: nab-paclitaxel IV;   Drug: CC-486;   Drug: Duravalumab
3 Recruiting To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;;   Rhabdomyosarcoma;;   Ewing's Sarcoma;;   Ewing's Tumor;;   Sarcoma, Ewing's;;   Sarcomas, Epitheliod;;   Sarcoma, Soft Tissue;;   Sarcoma, Spindle Cell;;   Melanoma;;   Malignant Melanoma;;   Clinical Oncology;;   Oncology, Medical;;   Pediatrics, Osteosarcoma;;   Osteogenic Sarcoma;;   Osteosarcoma Tumor;;   Sarcoma, Osteogenic;;   Tumors;;   Cancer;;   Neoplasia;;   Neoplasm;;   Histiocytoma;;   Fibrosarcoma;;   Dermatofibrosarcoma
Intervention: Drug: nab-paclitaxel
4 Recruiting Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
Condition: Squamous Cell Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Abraxane (Induction);   Drug: Carboplatin (Induction);   Drug: Abraxane (Maintenance);   Other: Best Supportive Care (Maintenance)
5 Recruiting Treatment of Pancreatic Cancer With Abraxane
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Abraxane;   Drug: Gemcitabine
6 Recruiting Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)
Condition: Pancreatic Neoplasms
Interventions: Drug: nab-Paclitaxel;   Drug: Gemcitabine;   Drug: Chemoradiation;   Drug: Capecitabine;   Procedure: Surgery
7 Recruiting Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Pancreatic Neoplasms
Interventions: Drug: nab-Paclitaxel;   Drug: Nivolumab;   Drug: Gemcitabine;   Drug: Carboplatin
8 Recruiting Study of 5-fluorouracil (5-FU), Nab-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer
Condition: Metastatic Pancreas Adenocarcinoma
Interventions: Drug: 5FU;   Drug: nab-paclitaxel;   Drug: bevacizumab;   Drug: calcium leucovorin;   Drug: oxaliplatin
9 Recruiting A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention:
10 Recruiting Single Arm on the Tolerability of Weekly Nab-paclitaxel
Condition: Non Small Cell Lung Cancer (NSCLC)
Intervention: Drug: Nab-Paclitaxel
11 Recruiting Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Condition: Gastroesophageal Cancer
Interventions: Drug: nab-paclitaxel;   Biological: ramucirumab
12 Recruiting Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers
Condition: Biliary Tract Cancer
Interventions: Drug: Abraxane (Nab-Paclitaxel);   Drug: Cisplatin;   Drug: Gemcitabine;   Behavioral: Phone Calls
13 Recruiting Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Palbociclib;   Drug: Nab-Paclitaxel
14 Recruiting Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC
Condition: STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Interventions: Drug: NAB-PACLITAXEL;   Drug: PACLITAXEL
15 Not yet recruiting Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
Conditions: Urothelial Carcinoma;   Bladder Cancer;   Transitional Cell Carcinoma
Interventions: Drug: nab-paclitaxel;   Drug: Gemcitabine
16 Recruiting The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)
Conditions: Esophageal Cancer;   Toxicity
Intervention: Drug: Nab-paclitaxel
17 Recruiting Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Lung Cancer
Condition: Small Cell Lung Cancer (SCLC)
Interventions: Drug: Nab-paclitaxel;   Drug: Gemcitabine
18 Recruiting NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma
Condition: Cancer of Stomach
Interventions: Drug: nab-paclitaxel;   Drug: FOLFOX
19 Recruiting Combining Abraxane With Capecitabine and Radiation Therapy for Consolidation of Treatment Following Induction Chemotherapy for Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Abraxane;   Drug: Capecitabine;   Radiation: Radiation Therapy;   Behavioral: Questionnaires
20 Recruiting A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
Condition: Carcinoma, Non-small-Cell Lung
Interventions: Drug: Necitumumab;   Drug: Nab-Paclitaxel;   Drug: Carboplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.